Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BROS vs GSK✓SelectedUSD · GSKBROS vs GSK performance historyLatest closeAs of-4.01%11/20
Stock and ETF performance explorer

BROS vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-35.6%
GSK return
+6.1%
Excess return
-41.7%
Maximum drawdown
-55.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.0%-0.1%-3.9%-4.0%
7D-8.7%-5.3%-3.4%-7.5%
30D-22.4%-3.7%-18.8%-21.6%
3M-33.6%-7.3%-26.3%-32.6%
6M-40.5%-4.2%-36.3%-40.1%
YTD-46.5%+0.9%-47.3%-48.7%
1Y-35.6%+7.3%-42.8%-41.3%
All-35.6%+6.1%-41.7%-41.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling